pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function
Lipid nanoparticles (LNPs) are advanced core-shell particles for messenger RNA (mRNA) based therapies that are made of polyethylene glycol (PEG) lipid, distearoylphosphatidylcholine (DSPC), cationic ionizable lipid (CIL), cholesterol (chol), and mRNA. Yet the mechanism of pH-dependent response that is believed to cause endosomal release of LNPs is not well understood. Here, we show that eGFP (enhanced green fluorescent protein) protein expression in the mouse liver mediated by the ionizable lipids DLin-MC3-DMA (MC3), DLin-KC2-DMA (KC2), and DLinDMA (DD) ranks MC3 ≥ KC2 > DD despite similar delivery of mRNA per cell in all cell fractions isolated. We hypothesize that the three CIL-LNPs react differently to pH changes and hence study the structure of CIL/chol bulk phases in water. Using synchrotron X-ray scattering a sequence of ordered CIL/chol mesophases with lowering pH values are observed. These phases show isotropic inverse micellar, cubic Fd3m inverse micellar, inverse hexagonal
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
ACS Nano
6 publications, 7.06%
|
|
|
Molecular Pharmaceutics
6 publications, 7.06%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
5 publications, 5.88%
|
|
|
Journal of Controlled Release
4 publications, 4.71%
|
|
|
Advanced Drug Delivery Reviews
3 publications, 3.53%
|
|
|
Advanced Science
3 publications, 3.53%
|
|
|
Expert Opinion on Drug Delivery
3 publications, 3.53%
|
|
|
Journal of the American Chemical Society
3 publications, 3.53%
|
|
|
Journal of Colloid and Interface Science
2 publications, 2.35%
|
|
|
bioRxiv
2 publications, 2.35%
|
|
|
Pharmaceutics
2 publications, 2.35%
|
|
|
Angewandte Chemie - International Edition
2 publications, 2.35%
|
|
|
Angewandte Chemie
2 publications, 2.35%
|
|
|
ACS applied materials & interfaces
2 publications, 2.35%
|
|
|
Advanced healthcare materials
2 publications, 2.35%
|
|
|
European Journal of Pharmaceutics and Biopharmaceutics
1 publication, 1.18%
|
|
|
Bioanalysis
1 publication, 1.18%
|
|
|
Extracellular Vesicles and Circulating Nucleic Acids
1 publication, 1.18%
|
|
|
Current Opinion in Chemical Biology
1 publication, 1.18%
|
|
|
International Journal of Pharmaceutics: X
1 publication, 1.18%
|
|
|
Carbohydrate Polymers
1 publication, 1.18%
|
|
|
Langmuir
1 publication, 1.18%
|
|
|
Molecular Aspects of Medicine
1 publication, 1.18%
|
|
|
Scientia Sinica Chimica
1 publication, 1.18%
|
|
|
Chemical Engineering Journal
1 publication, 1.18%
|
|
|
Advanced Materials
1 publication, 1.18%
|
|
|
Frontiers in Medical Engineering
1 publication, 1.18%
|
|
|
Nanomedicine
1 publication, 1.18%
|
|
|
International Journal of Pharmaceutics
1 publication, 1.18%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
|
|
|
American Chemical Society (ACS)
20 publications, 23.53%
|
|
|
Elsevier
17 publications, 20%
|
|
|
Wiley
12 publications, 14.12%
|
|
|
Cold Spring Harbor Laboratory
8 publications, 9.41%
|
|
|
MDPI
6 publications, 7.06%
|
|
|
Taylor & Francis
6 publications, 7.06%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
5 publications, 5.88%
|
|
|
Springer Nature
5 publications, 5.88%
|
|
|
Royal Society of Chemistry (RSC)
3 publications, 3.53%
|
|
|
OAE Publishing Inc.
1 publication, 1.18%
|
|
|
Science in China Press
1 publication, 1.18%
|
|
|
Frontiers Media S.A.
1 publication, 1.18%
|
|
|
5
10
15
20
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.